© 1995 British Society for Rheumatology
research-article |
THE EFFECT OF SYSTEMIC LUPUS ERYTHEMATOSUS AND LONG-TERM STEROID THERAPY ON BONE MASS IN PRE-MENOPAUSAL WOMEN
,
*Department of Nuclear Medicine, Hospital Clinic i Provincial, University of Barcelona Barcelona, Spain
Department of Rheumatology, Hospital Clinic i Provincial, University of Barcelona Barcelona, Spain
Department of Internal Medicine, Metabolic Bone Diseases and Systemic Autoimmune Diseases Units, Hospital Clinic i Provincial, University of Barcelona Barcelona, Spain
Correspondence to:
Correspondence to: P. Peris, Servicio de Reumatologia, Hospital Clinic i Provincial, Villarroel 170, 08036 Barcelona, Spain.
The aim of our study was to assess bone mineral density (BMD) in pre-menopausal women with systemic lupus erythematosus (SLE) and the influence of disease activity and use of corticosteroids. Lumbar and femoral BMD were measured in 43 patients with SLE (28 on regular steroid therapy, 15 with recent onset, non-treated) and compared with 43 healthy women matched for age. In addition, 21 SLE patients treated with corticosteroids were followed-up with a mean of 36.6±12.7 months. BMD was significantly lower in SLE patients with prednisone doses 
7.5 mg/day than those of recent onset (lumbar: 1.07±0.11 vs 1.15±0.13, P=0.039; femur 0.85±0.13 vs 0.98±0.21, P = 0.034) and the control group (lumbar: 1.07±0.11 vs 1.13±0.10, P = 0.040; femur: 0.85±0.13 vs 0.93±0.10, P = 0.028). In addition, 18% of SLE steroid users had osteoporosis. Lumbar and femoral BMD were inversely correlated with the time of treatment and the cumulative doses of prednisone. There were no significant BMD changes during the 3-yr follow-up period. In conclusion, in SLE pre-menopausal patients lumbar and femoral BMD is decreased and related to long-term corticosteroid therapy.
KEY WORDS: Corticosteroids, Prednisone, Osteoporosis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Regio, E Bonfa, L Takayama, and R. Pereira The influence of lean mass in trabecular and cortical bone in juvenile onset systemic lupus erythematosus Lupus, September 1, 2008; 17(9): 787 - 792. [Abstract] [PDF]
|
|
|
|
|
|
V. Lilleby Review: Bone status in juvenile systemic lupus erythematosus Lupus, August 1, 2007; 16(8): 580 - 586. [Abstract] [PDF]
|
|
|
|
|
|
C C Mok, A Mak, and K M Ma Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus Lupus, February 1, 2005; 14(2): 106 - 112. [Abstract] [PDF]
|
|
|
|
 |
|
 C-S Yee, N Crabtree, J Skan, N Amft, S Bowman, D Situnayake, and C Gordon Prevalence and predictors of fragility fractures in systemic lupus erythematosus Ann Rheum Dis, January 1, 2005; 64(1): 111 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C A Pineau, M B Urowitz, P J Fortin, D Ibanez, and D D Gladman Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density Lupus, June 1, 2004; 13(6): 436 - 441. [Abstract] [PDF]
|
|
|
|
|
|
Y Molad, A Gorshtein, A J Wysenbeek, D Guedj, R Majadla, A Weinberger, and M Amit-Vazina Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort{ Lupus, June 1, 2002; 11(6): 356 - 361. [Abstract] [PDF]
|
|
|
|
|
|
D Schapira, A Kabala, B Raz, and E Israeli Osteoporosis in murine systemic lupus erythematosus - a laboratory model Lupus, June 1, 2001; 10(6): 431 - 438. [Abstract] [PDF]
|
|
|
|
|
|
D Sen and R W Keen Osteoporosis in systemic lupus erythematosus: prevention and treatment Lupus, March 1, 2001; 10(3): 227 - 232. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Jardinet, C. Lefebvre, G. Depresseux, M. Lambert, J.-P. Devogelaer, and F. A. Houssiau Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine Rheumatology, April 1, 2000; 39(4): 389 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Urowitz and D. D. Gladman How to improve morbidity and mortality in systemic lupus erythematosus Rheumatology, March 1, 2000; 39(3): 238 - 244. [Full Text] [PDF]
|
|
|
|
|
|
I.-M. Gilboe, T. K Kvien, G. Haugeberg, and G. Husby Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls Ann Rheum Dis, February 1, 2000; 59(2): 110 - 115. [Abstract] [Full Text]
|
|
|
|
|
|
F. Formiga, J. Nolla, F. Mitjavila, R. Bonnin, M. Navarro, and I. Moga Bone mineral density and hormonal status in men with systemic lupus erythematosus Lupus, December 1, 1996; 5(6): 623 - 626. [Abstract] [PDF]
|
|